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Abstract: Asbestos exposure causes significant pleural diseases, including malignant pleural 
mesothelioma (MPM). Taking into account the impact of MPM on emotional functioning and 
wellbeing, this study aimed to evaluate the quality of life and personality traits in patients with 
MPM and their first-degree caregivers through the World Health Organization Quality of Life–
BREF (WHOQOL-BREF) and the Minnesota Multiphasic Personality Inventory-2 Restructured 
Form (MMPI-2-RF). The sample was composed of 27 MPM patients, 55 first-degree relatives 
enrolled in Casale Monferrato and Monfalcone (Italy), and 40 healthy controls (HC). Patients 
and relatives reported poorer physical health than the HC. Patients had a higher overall sense 
of physical debilitation and poorer health than relatives and the HC, more numerous complaints 
of memory problems and difficulties in concentrating, and a greater belief that goals cannot 
be reached or problems solved, while often claiming that they were more indecisive and inef-
ficacious than the HC. First-degree relatives reported lower opinions of others, a greater belief 
that goals cannot be reached or problems solved, support for the notion that they are indecisive 
and inefficacious, and were more likely to suffer from fear that significantly inhibited normal 
activities than were HC. In multinomial regression analyses, partial models indicated that 
sex, physical comorbidities, and the True Response Inconsistency (TRIN-r), Malaise (MLS), 
and Behavior-Restricting Fears (BRF) dimensions of the MMPI-2-RF had significant effects 
on group differences. In conclusion, health care providers should assess the ongoing adjust-
ment and emotional wellbeing of people with MPM and their relatives, and provide support to 
reduce emotional distress.
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Introduction
Asbestos is a generic term used to identify a number of well-known silicate  minerals, 
which may produce thin and flexible fibers when crushed; in the last century 
 asbestos was extensively used because of its thermoelectrical and sound absorptive 
 properties, as well as its resistance to chemical and biological agents.1 Asbestos 
exposure is  responsible for several pleural diseases, including pleural plaques, diffuse 
 pleural  thickening, benign asbestos-related pleural effusions, and malignant pleural 
 mesothelioma (MPM).2
MPM is a rare and rapidly fatal tumor that is closely related to the inhalation of 
asbestos fibers and accounts for approximately 1% of all cancer deaths in the world.3 
In Italy, the Italian National Register, the national surveillance system of MPM, 
recorded a case list of 8,868 MPM between 1993 and 2004, equivalent to standardized 
incidence rates of 3.49 per 100,000 inhabitants for men and 1.25 for women, with a 
wide interregional variability.4
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MPM is recognized as a disease that is mostly  associated 
with occupational exposure, though in some cases, the 
 exposure may occur in the environment near industrial 
or  natural sources of asbestos. Cases of indirect exposure 
can also be found among those who live with people 
who are occupationally exposed to asbestos.5 In Italy, 
Marinaccio et al4 reported that over 69% of the patients with 
MPM they interviewed had been exposed to asbestos in an 
occupational setting; 4.4% of patients were the result of 
cohabitating with someone who was occupationally exposed; 
and 6% of the respondents were exposed to asbestos through 
the general environment or leisure activities.
Despite advances in chemotherapy, radiotherapy, and 
surgical approaches, MPM remains largely resistant to treat-
ment, with an estimated median survival time of 9 months.6 
The impact of MPM is multidimensional and is associated 
with several physical symptoms (eg, pain, breathlessness, 
fatigue, cough, sleep disturbance, appetite loss, and sweat-
ing), lower emotional functioning (eg, anxiety, depression, 
fear, and isolation), and changes in social roles and interper-
sonal relationships.7
Despite MPM’s severe impact on emotional functioning 
and the wellbeing of individuals and their families, most 
information about the quality of life (QoL) of patients with 
MPM and their caregivers is anecdotal, and systematic stud-
ies are rare. Recently, the British Lung Foundation (BLF) 
survey of MPM patients and their caregivers indicated that 
emotional functioning in patients with MPM and their family 
members is significantly impaired.8,9 Furthermore, caregivers 
reported higher levels of personal distress than did patients, 
received less guidance and support, and were far less likely 
to feel well-informed throughout the process of diagnosis.8
Thus, the aim of this study was to investigate both the 
QoL and personality of patients with MPM and their caregiv-
ers (ie, the relatives or family members who provide direct 
care to the person with MPM). We hypothesized that both 
patients with MPM and their relatives who provide direct 
care and support may have a poor QoL.
Methods
Design and procedure
This was a cross-sectional study investigating QoL in patients 
with MPM and their caregivers. The cases used in this study 
involved patients with MPM who lived in Casale Monferrato 
and Monfalcone. To enroll cases, flyers were sent to some 
nonprofit organizations that were active in Casale  Monferrato 
and Monfalcone, such as the Relatives and Victims of 
Asbestos Association, the Exposed to Asbestos Association, 
and the Work Invalids and Maimed National Association. 
 Furthermore, the researchers contacted physicians of the 
Santo Spirito Hospital in Casale Monferrato, who pub-
licized the research to their patients. Casale Monferrato 
and  Monfalcone were selected as centers to enroll patients 
because in these towns there are the most important facilities 
for the treatment of asbestos in Italy.
In order to be included in the study patients had to be 
18 years of age and over and be diagnosed with MPM. 
Patients were excluded if they were at the terminal stage of 
the disease, had any disease of the central nervous system or 
major medical comorbidities (eg, diabetes, cardiac disease, 
or non-MPM tumors that were or were not associated with 
asbestos exposure), or any diagnosis on Axis I or Axis II of 
the Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition−text revised (DSM-IV-TR).10 First-degree rela-
tives were expected to live in the same geographical areas 
of the patients, be 18 years or older, and provide direct care 
and support to the person with MPM. First-degree relatives 
were excluded from the study if they had any disease of the 
central nervous system, major medical conditions including 
MPM or other diseases associated with asbestos exposure, 
or any DSM-IV-TR diagnosis.10
Controls were selected using judgmental sampling in 
towns homogeneous to Casale Monferrato and Monfalcone 
for geographical area, population density and demographic 
stratification. Subjects were recruited among people who 
were not exposed to asbestos, using flyers that were sent 
to nonprofit organizations that were active in both areas. 
The same inclusion/ exclusion criteria as for first-degree 
relatives were used for the control group.
All subjects participated anonymously in the study 
and gave their informed consent. The study protocol was 
approved by the local Institutional Review Board (IRB).
Participants
In total, 153 subjects were enrolled in the study, but 19 patients 
(12% of the total) died before the assessment was complete. 
Similarly, 12 subjects (8% of the total) were excluded 
because they either did not complete the World Health 
Organization Quality of Life–BREF (WHOQOL-BREF)12 
(31%) or the Minnesota Multiphasic Personality Inventory-2 
Restructured Form (MMPI-2-RF)13 (32%), or because they 
had an invalid profile in the MMPI-RF (37%).
The final sample was composed of 27 patients (eight 
women and 19 men) affected by MPM, with a mean age 
of 61.41 ± 8.82 years; 55 first-degree relatives (43 women 
and 12 men), with a mean age of 56.51 ± 13.66 years; 
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and 40 healthy controls (22 women and 18 men), with a 
mean age of 44.63 ± 13.02 years.
All the patients had occupational exposure to asbestos. 
The diagnosis of MPM was made between January and June 
2010, and they all claimed to have received treatment for 
MPM, including surgery, radiotherapy, chemotherapy, and 
immunotherapy.11
Measures
Subjects were administered the WHOQOL-BREF12 in order 
to measure QoL, and the MMPI-2-RF.13 The WHOQOL-
BREF is a 26 item self-report questionnaire measuring four 
broad domains of QoL: physical health, psychological health, 
social relationships, and environmental health.
The MMPI-2-RF is a revised, 338-item version of the 
MMPI-2 that is conceptually and empirically linked to mod-
ern theories and models of psychopathology and  personality. 
It is composed of 51 scales: nine validity scales, three 
higher-order scales, nine restructured clinical scales (RC), 
five somatic/cognitive scales, nine internalizing scales, four 
externalizing scales, five interpersonal scales, two interest 
scales, and five personality psychopathology scales (see 
Table 1 for descriptions of the dimensions). The Italian 
adaptation of the MMPI-2-RF has psychometric proper-
ties that have been found to be comparable to those of the 
American version.14 Factor analyses on the higher-order and 
the RC scales conducted on a 1,234 normative sample and 
464 psychiatric patients confirmed the factorial structure 
of the original version. Moreover, internal consistency esti-
mates were comparable to those found with the American 
population, and good discriminant and concurrent validity 
were found.14
statistical analysis
Chi-squared tests (χ2) and analysis of variance tests 
(ANOVA) were used for bivariate analyses. Benjamini and 
Hochberg’s correction was used for multiple testing.15 When 
ANOVAs were significant after correction for multitesting, 
we used Tamhane’s T2 tests for post hoc comparisons among 
groups. All variables that were significant at the bivariate 
analyses after correction for multitesting were inserted as 
independent variables in a series of multinomial regression 
analyses with groups as criteria. Due to the higher number 
of variables included in the study and the lower number of 
subjects included in some groups, we performed three analy-
ses with single blocks of variables: in the first model, we 
inserted sociodemographic variables; in the second model, 
we inserted the validity scales of the MMPI-2-RF; and in 
the third model, we inserted the clinical scales of the MMPI-
2-RF. In a final model, we inserted all the variables that had 
been significant in the previous analyses and the WHOQOL 
Physical Health. As measures of model fit, we reported the 
-2 log likelihood statistic (-2 LL), the likelihood χ2, and the 
Pearson’s χ2. As measures of effects significance, we reported 
the -2 LL for reduced model and the likelihood ratio test. 
As measures of association, we reported odds ratios (OR) 
and their 95% confidence intervals (CI). ORs greater than 
1 indicated a higher risk for patients or their relatives when 
compared with healthy controls.
All the analyses were performed with the statistical pack-
age for the social sciences SPSS for Windows 19.0 (IBM, 
Armonk, NY, USA).
Results
Differences among groups
Table 2 lists the sociodemographic characteristics of the 
groups. Groups differed for most sociodemographic vari-
ables even after the correction for multitesting. The healthy 
controls (compared with the other groups) were younger, 
more likely to be women, more likely to live alone, and were 
less likely to have had low school attainment. The controls 
also had a lower rate of physical comorbidities than did the 
other groups. Finally, the groups did not differ in terms of 
employment.
The groups differed only on one single dimension of the 
WHOQOL (see Table 3). Both patients and their relatives 
reported poorer physical health than did the healthy controls. 
Despite this, the raw scores on psychological health and 
environmental health were lower for patients and their rela-
tives than for controls. The differences were not significant 
after controlling for multitesting.
The groups also differed on several dimensions of the 
MMPI-2-RF (see Table 4). Patients had a higher overall 
sense of physical debilitation and poorer health (MLS) than 
did first-degree relatives and healthy controls and complained 
of memory problems and difficulties in concentrating (COG) 
more often than did the healthy controls. They were also more 
likely to believe that goals cannot be reached or problems 
solved (HLP) and that they were more indecisive and inef-
ficacious (NFC) than were the healthy controls.
First-degree relatives of patients reported lower opinions 
of others (RC3), were more likely to believe that goals can-
not be reached or problems solved (HLP) and often thought 
themselves to be more indecisive and inefficacious (NFC) 
than did the healthy controls (see Table 4). Furthermore, 
they were more likely to report the presence of fears that 
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Table 1 Acronyms and description of each dimension of the Minnesota Multiphasic Personality Inventory-2 Restructured Form 
(MMPI-2-RF)
Validity scales: revised version of seven MMPI-2 validity indicators, one new infrequency scale, and one new measure of response bias
VRIN-r Variable response inconsistency random responding
TRIN-r True response inconsistency Fixed responding
F-r infrequent responses responses infrequent in the general population
Fp-r infrequent Psychopathology responses responses infrequent in psychiatric populations
Fs infrequent somatic responses somatic complaints infrequent in medical patients
FBS-r symptom Validity Somatic and cognitive complaints associated at high levels with over-reporting
rBs response Bias Non credible memory complaints
L-r Uncommon Virtues rarely claimed moral attributes
K-r adjustment Validity avowals of good psychological adjustment associated at high levels with underreporting
Higher-order (H-O) scales: broad dimensional scales measuring emotional, thought, and behavioral dysfunction
eiD emotional/internalizing Dysfunction Symptoms and difficulties associated with mood and affect
ThD Thought Dysfunction Problems associated with thought disturbance
BXD Behavioral/externalizing Dysfunction Problems associated with behavioral acting-out proclivities
Cognitive scales
Mls Malaise Overall sense of physical debilitation and poor health
gic gastrointestinal complaints complaints about recurring upset stomach, vomiting, nausea
hPc head Pain complaints complaints about head and neck pain
NUc Neurological complaints Various neurological complaints such as dizziness, weakness, loss of control over movement
cOg cognitive complaints Complaints associated with memory problems and difficulties concentrating
Interpersonal Scales
FMl Family Problems Negative family experiences
iPP interpersonal Passivity Being submissive and unassertive
saV social avoidance avoiding or not enjoying social events
shY shyness Feeling uncomfortable and anxious around others
DsF Disaffiliativeness Disliking people and being around them
Restructured Clinical (RC) Scales: assessing the valuable descriptive and distinctive core features of the MMPI-2 Clinical Scales
RCd-(dem) Demoralization Unhappiness and life dissatisfaction
RC1-(som) somatic complaints Multiple physical health complaints
RC2-(lpe) low Positive emotions lack of positive emotional experiences
RC3-(cyn) cynicism Non self-reliant beliefs expressing a highly negative view of human nature
RC4-(asb) antisocial Behavior Behavior that fails to conform to societal norms and expectations
RC6-(per) ideas of Persecution Persecutory self-referential beliefs
RC7-(dne) Dysfunctional Negative emotions Negative emotional experiences, such as maladaptive anxiety and irritability
RC8-(abx) aberrant experiences Unusual thoughts and perceptual experiences
RC9-(hpm) hypomanic activation Over-activation, mood instability, poor impulse control
Personality Psychopathology Five (PSY-5) Scales, revised
AGGR-r Aggressiveness-revised instrumentally aggressive behavior
PSYC-r Psychoticism-revised experiences associated with thought disturbance
DISC-r Disconstraint-revised Poor controlled behavior
NEGE-r Negative Emotionality/Neuroticism-revised anxiety, insecurity, and fear
INTR-r Introversion/Low Positive Emotionality-revised avoidance of social situations and low positive emotional experiences
Internalizing scales
sUi suicidal/Death ideation reports of suicidal ideation and attempts
hlP helplessness/hopelessness Belief that problems cannot be overcome and feeling pessimistic
sFD Self-Doubt Lack of confidence and feeling useless
NFc Inefficacy Belief that one is incapable of making decisions
sTW stress/Worry Preoccupation with disappointments and with time pressure
aXY anxiety Significant anxiety and anxiety related problems
aNP anger Proneness Becoming easily upset, impatient and irritable
BrF Behavior-Restricting Fears Fears that significantly inhibit normal activities
MsF Multiple Specific Fears Disparate specific fears of blood, fire, thunder, etc
Externalizing scales
JcP Juvenile conduct Problems Undesirable school and home conduct
sUB substance abuse current and past alcohol and drugs abuse
agg aggression Violent and physically aggressive behavior
acT activation heightened excitation and energy level
(Continued)
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Variables 1 2 3 Test P, Post hoc tests 
Mean differencePatients 
(N = 27)
First-degree caregivers 
(N = 55)
Healthy controls 
(N = 40) 12 13 23
Women 29.6% 78.2% 55.0% χ22 = 18.34 ,0.001**
age 61.41 ± 8.82 56.51 ± 13.66 44.63 ± 13.02 F2;119 = 16.95 ,0.001** 4.90 16.78* 11.88*
living alone 48.0 56.4 90.0 χ22 = 16.11 ,0.001**
school #8 years 60.0 47.3 7.5 χ22 = 23.18 ,0.001**
Job χ24 = 6.76 0.15
employed 88.5 75.5 75.5
Unemployed 7.7 3.8 3.8
Other 3.8 20.8 20.8
Physical comorbidities 92.0 59.3 30.8 χ24 = 23.52 ,0.001**
Notes: Benjamini-Hochberg correction for multitesting. *Significant for P , 0.05; **significant for P , 0.01. Tamhane’s post hoc tests.
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Table 1 (Continued)
Interest scales
aes Aesthetic-Literary Interests interest about activities such as theatre or music
Mec Mechanical-Physical Interests Interests about activities such as fixing and building things
significantly inhibit normal activities (BRF) than were the 
healthy controls.
There were also differences in the validity scales of the 
MMPI-2-RF (see Table 3). Patients and their first-degree 
relatives had higher scores on True Response Inconsistency 
(TRIN-r), Infrequent Responses (F-r), Infrequent Somatic 
Responses (Fs), and Symptom Validity (FBS-r) than did the 
controls. Thus, these groups endorsed “true” response more 
incoherently (fixed responding), and they more frequently 
endorsed responses that were infrequent in the general popu-
lation, somatic complaints that were infrequent in medical 
populations, and somatic and cognitive complaints associated 
with higher levels of overreporting.
All the variables significant at the bivariate analyses were 
inserted as independent variables in a series of multinomial 
regression analyses, with groups as criteria (see Tables 5 
and 6). The partial models indicated that sex, physical comor-
bidities, and the TRIN-r, MLS, and BRF dimensions of the 
MMPI-2-RF had significant effects on group differences (see 
Table 5). These variables were inserted into a final model, 
which fitted the data well and explained 66% of the variability 
of the data (Nagelkerke R2 = 0.66) (see Table 6).
In the final model, all the independent variables, except 
for the BRF and physical health, had a significant effect on 
group differences. Patients (compared with healthy con-
trols) were: less likely to be women (OR = 0.12; 95% CI: 
0.02−0.78) (P , 0.05); less likely to live alone (OR = 0.08; 
95% CI: 0.01−0.51) (P , 0.01); more likely to have 
physical comorbidities (OR = 27.43; 95% CI: 3.17−237.50) 
(P , 0.01); and more likely to report higher scores on the 
TRIN-r (OR = 1.99; 95% CI: 1.22−3.22) (P , 0.01) and 
on the MLS (OR = 1.88; 95% CI: 1.15−3.08) (P , 0.05). 
First-degree relatives (compared with healthy controls) were: 
less likely to live alone (OR = 0.20; 95% CI: 0.05−0.80) 
(P , 0.05); and more likely to have had lower amounts of 
schooling (OR = 5.16; 95% CI: 3.17−237.50) (P , 0.05).
Discussion
Previous studies have indicated that family members of 
patients with cancer − particularly spouses − share many 
caregiving tasks.16,17 In our sample, patients with MPM were 
frequently men who were over 50-years-old. Their caregivers 
were frequently women who were over 50-years-old, indicat-
ing that the MPM patients’ wives were the ones who provided 
direct care to their relatives.
The sociodemographic characteristics of our sample are 
concordant with those of the sample that participated in the 
BLF survey.8 In fact, MPM was most commonly contracted 
by adult individuals working in male-dominated trades or 
industries during the period in which asbestos was most 
frequently used.
Patients with MPM reported significantly poorer physical 
health on the WHOQOL and higher scores on the MMPI-2-RF 
MLS (overall sense of physical debilitation and poor health) 
and COG (complaints associated with memory problems and 
difficulties concentrating) scales than did controls, and almost 
all had physical comorbidities. MPM patients also had lower 
scores on all areas of QoL investigated with the WHOQOL 
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Table 3 WHOQOL and validity scales of the MMPI-RF
Variables 1 2 3 Test P, Post hoc tests 
Mean differencePatients 
(N = 27)
First-degree relatives 
(N = 55)
Healthy controls 
(N = 40) 12 13 23
WHOQOL
Physical health 57.28 ± 15.83 63.95 ± 14.54 75.40 ± 11.58 F2;119 = 14.75 ,0.001** -6.67 -18.12* -11.45*
Psychological health 57.37 ± 15.34 61.09 ± 13.48 65.83 ± 10.77 F2;119 = 3.47 0.03
social health 62.50 ± 18.14 65.53 ± 14.97 69.17 ± 16.47 F2;119 = 1.39 0.25
environmental health 57.01 ± 16.20 56.23 ± 14.80 64.53 ± 11.73 F2;119 = 4.32 0.02
Validity scales
VRIN-r 5.04 ± 2.88 4.84 ± 2.43 4.30 ± 2.44 F2;119 = 0.81 0.45
TRIN-r 12.96 ± 2.43 11.96 ± 2.03 10.63 ± 1.55 F2;119 = 11.80 ,0.001** 1.00 2.34* 1.34*
F-r 6.11 ± 4.29 5.04 ± 4.30 3.13 ± 3.28 F2;119 = 4.98 0.008* 1.08 2.99* 1.91*
Fp-r 2.22 ± 1.95 2.25 ± 1.83 2.25 ± 1.63 F2;119 = 0.003 1.00
Fs 3.48 ± 2.23 2.35 ± 2.14 1.18 ± 1.65 F2;119 = 10.83 ,0.001** 1.14 2.31* 1.17*
FBS-r 11.74 ± 3.46 10.38 ± 4.48 8.10 ± 3.52 F2;119 = 7.40 0.001** 1.36 3.64* 2.28*
L-r 5.44 ± 2.04 5.55 ± 2.10 5.03 ± 2.85 F2;119 = 0.59 0.56
K-r 6.00 ± 2.50 5.87 ± 2.88 7.50 ± 2.91 F2;119 = 4.30 0.02
Notes: Benjamini-Hochberg correction for multitesting. *Significant for P , 0.05; **significant for P , 0.01. Tamhane’s post hoc tests.
Abbreviations: F-r, Infrequent Responses; FBS-r, Symptom Validity; Fp-r, Infrequent Psychopathology Responses; Fs, Infrequent Somatic Responses; K-r, Adjustment 
Validity; L-r, Uncommon Virtues; MMPI-RF, Minnesota Multiphasic Personality Inventory-2 Restructured Form; TRIN-r, True Response Inconsistency; VRIN-r, Variable 
response inconsistency; WhOQOl, World health Organization Quality of life.
(emotional, social, and environmental health), but the differ-
ences did not reach statistical significance.  Nevertheless, the 
differences in QoL between patients with MPM and controls 
were moderate in terms of both Psychological Health and 
Environmental Health (Cohen’s D = 0.53 [for  Environmental 
Health] to 0.64 [for Psychological Health]), with MPM 
patients complaining of poorer health. We did not directly 
investigate the presence of affective symptomatology, mood 
disturbances, and chronic pain, or emotions such as sadness, 
grief, anger, and anxiety.18 Such emotions may not have been 
associated only with illness per se, but possibly also with 
the fact that most of them were exposed to asbestos prior to 
the implementation of occupational safety standards − thus, 
patients and families may have felt anger towards employers 
who did not inform them of these types of environmental and 
workplace hazards.18 Finally, it has been seen that patients 
and families have distress linked to lengthy legal battles, 
as they seek financial compensation from their employers 
for having developed an occupationally associated illness.18 
In the BLF survey of MPM patients and their caregivers, 
approximately one out of two patients with MPM reported 
feeling depressed some or most of the time since diagnosis, 
67% of them reported feeling anxiety some or most of the 
time, and 59% reported feeling fear.8
The caregivers of MPM patients also reported poorer 
physical health than did the controls, and frequent comor-
bidities with physical illness.17 Their scores on other areas 
of QoL, as measured by the WHOQOL, were constantly 
higher than those of patients but lower than those of controls, 
except for environmental health, where they had the low-
est raw scores and where the difference between them and 
controls was moderate, although not significant (Cohen’s 
D = 0.62). This data could be linked to the fact they had 
been exposed to the fibers for years and now live in fear 
of succumbing to illness due to their long exposure to the 
carcinogenic stimulus.19
Our results are somewhat inconsistent with those of the 
BLF survey of MPM patients and their caregivers, in which 
more caregivers than patients with MPM reported that they 
had felt depressed since the diagnosis (around 80% of care-
givers reported feeling depressed some or most of the time). 
The BLF survey suggested that feeling isolated was another 
common emotion among the caregivers of MPM patients 
(in that study, around 78% of caregivers reported feeling 
isolated/alone some or most of the time). In our sample, the 
caregivers reported a poorer perception of the environment 
and significantly higher scores than did controls in the RC3. 
Caregivers typically display increasingly cynical behavior and 
are often unable to understand the selflessness and helpful-
ness of others, many of which are perceived as being alien 
and less inclined to help and provide support to the patient. 
The content of this scale focuses on a cynical view of human 
nature and a generally negative view of the motivations of 
other people, reflecting the key idea that other people are 
looking out for their own interests most of the time and can-
not be trusted.20
Neuropsychiatric Disease and Treatment 2013:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1199
Qol and personality traits in patients with mesothelioma
Table 4 Personality profile broken down by group
Variables 1 2 3 Test P, Post hoc tests 
Mean differencePatients 
(N = 27)
First-degree relatives 
(N = 55)
Healthy controls 
(N = 40) 12 13 23
MMPI-2-RF Higher-Order (H-O) and Restructured Clinical (RC) scales
eiD 14.96 ± 6.24 13.93 ± 8.09 11.68 ± 6.72 F2;119 = 1.89 0.16
ThD 4.56 ± 3.84 3.91 ± 3.51 2.45 ± 2.96 F2;119 = 3.54 0.03
BXD 5.52 ± 3.30 4.60 ± 2.76 5.98 ± 4.68 F2;119 = 1.78 0.17
rcd 8.74 ± 4.97 7.56 ± 6.24 5.20 ± 4.90 F2;119 = 3.70 0.03
rc1 8.00 ± 3.28 7.78 ± 4.70 5.68 ± 4.19 F2;119 = 3.54 0.03
rc2 5.00 ± 2.66 4.67 ± 2.85 4.83 ± 2.69 F2;119 = 0.13 0.88
rc3 9.26 ± 3.05 9.25 ± 2.84 7.33 ± 3.79 F2;119 = 4.83 0.01* 0.01 1.93 1.93*
rc4 4.15 ± 2.94 3.56 ± 2.27 5.00 ± 4.54 F2;119 = 2.18 0.12
rc6 2.56 ± 2.33 2.25 ± 2.33 1.48 ± 1.69 F2;119 = 2.45 0.09
rc7 8.56 ± 4.59 8.69 ± 5.15 6.45 ± 4.67 F2;119 = 2.73 0.07
rc8 4.44 ± 3.72 3.31 ± 3.05 2.28 ± 3.06 F2;119 = 3.72 0.03
rc9 12.56 ± 4.64 11.47 ± 4.23 11.20 ± 5.01 F2;119 = 0.757 0.47
MMPI-2-RF Somatic/Cognitive and Internalizing Scales
Mls 4.74 ± 2.09 2.96 ± 2.01 2.33 ± 1.62 F2;119 = 13.36 ,0.001** 1.78* 2.42* 0.64
gic 0.93 ± 1.44 0.80 ± 1.22 0.40 ± 1.01 F2;119 = 1.89 0.16
hPc 1.85 ± 1.13 2.07 ± 1.70 1.20 ± 1.22 F2;119 = 4.35 0.02
NUc 2.59 ± 1.69 2.31 ± 1.71 2.23 ± 1.82 F2;119 = 0.38 0.69
cOg 3.56 ± 2.75 2.29 ± 2.46 1.60 ± 1.96 F2;119 = 5.49 0.01* 1.27 1.96* 0.69
sUi 0.56 ± 0.75 0.49 ± 0.79 0.15 ± 0.43 F2;119 = 3.86 0.02
hlP 2.59 ± 1.28 2.22 ± 1.26 1.40 ± 0.87 F2;119 = 9.96 ,0.001** 0.37 1.19* 0.82*
sFD 1.11 ± 1.09 1.13 ± 1.17 0.60 ± 0.90 F2;119 = 3.20 0.04
NFc 4.85 ± 2.43 4.45 ± 2.57 3.00 ± 2.32 F2;119 = 5.83 0.004* 0.40 1.85* 1.46*
sTW 3.22 ± 1.50 3.20 ± 1.52 2.75 ± 1.69 F2;119 = 1.14 0.33
aXY 1.30 ± 1.10 1.27 ± 1.27 0.68 ± 0.86 F2;119 = 3.99 0.02
aNP 2.15 ± 1.79 2.16 ± 1.61 1.95 ± 1.74 F2;119 = 0.21 0.82
BrF 2.00 ± 1.21 2.67 ± 1.83 1.45 ± 1.43 F2;119 = 7.02 0.001** -0.67 0.55 1.22*
MsF 3.67 ± 2.08 4.29 ± 2.43 3.43 ± 2.19 F2;119 = 1.81 0.17
Externalizing, Interpersonal, and Interest Scales
JcP 1.37 ± 1.52 0.91 ± 0.93 1.43 ± 1.66 F2;119 = 2.06 0.13
sUB 0.48 ± 0.75 0.36 ± 1.10 1.00 ± 1.40 F2;119 = 3.77 0.03
agg 2.44 ± 1.60 2.05 ± 1.38 2.15 ± 1.89 F2;119 = 0.54 0.59
acT 2.78 ± 1.55 2.65 ± 1.72 2.33 ± 1.69 F2;119 = 0.71 0.50
FMl 2.04 ± 1.87 1.80 ± 2.04 2.30 ± 2.27 F2;119 = 0.67 0.51
iPP 2.89 ± 1.76 2.87 ± 1.90 3.08 ± 2.34 F2;119 = 0.13 0.88
saV 2.89 ± 2.08 3.55 ± 2.37 3.43 ± 2.75 F2;119 = 0.67 0.51
shY 2.96 ± 1.99 2.64 ± 2.35 2.05 ± 2.04 F2;119 = 1.57 0.21
DsF 0.85 ± 1.03 0.87 ± 1.20 0.55 ± 1.09 F2;119 = 1.06 0.35
aes 2.33 ± 1.66 3.16 ± 1.86 2.98 ± 1.70 F2;119 = 2.03 0.14
Mec 2.41 ± 1.85 1.45 ± 1.41 1.43 ± 1.63 F2;119 = 3.89 0.02
Personality Psychopathology Five (PSY-5) Scales
AGGR-r 10.56 ± 2.59 10.07 ± 2.67 9.85 ± 3.26 F2;119 = 0.50 0.61
PSYC-r 5.00 ± 3.89 4.24 ± 3.75 2.75 ± 3.21 F2;119 = 3.51 0.03
DISC-r 5.19 ± 3.00 4.44 ± 2.62 5.45 ± 4.08 F2;119 = 1.23 0.30
NEGE-r 8.30 ± 3.12 8.71 ± 3.78 6.90 ± 3.77 F2;119 = 2.95 0.06
INTR-r 6.81 ± 2.94 7.36 ± 3.23 7.33 ± 3.61 F2;119 = 0.28 0.76
Notes: Benjamini-Hochberg correction for multitesting. *Significant for P , 0.05; **significant for P , 0.01. Tamhane’s post hoc tests.
Abbreviations: ACT, Activation; AES, Aesthetic-Literary Interests; AGG, Aggression; AGGR-r, Aggressiveness-revised; ANP, Anger Proneness; AXY, Anxiety; BRF, 
Behavior-Restricting Fears; BXD, Behavioral/Externalizing Dysfunction; COG, Cognitive Complaints; DISC-r, Disconstraint-revised; DSF, Disaffiliativeness; EID, Emotional/
Internalizing Dysfunction; FML, Family Problems; GIC, Gastrointestinal Complaints; HLP, Helplessness/Hopelessness; HPC, Head Pain Complaints; INTR-r, Introversion/Low 
Positive Emotionality-revised; IPP, Interpersonal Passivity; JCP, Juvenile Conduct Problems; MEC, Mechanical-Physical Interests; MLS, Malaise; MMPI, Minnesota Multiphasic 
Personality Inventory-2 Restructured Form; MSF, Multiple Specific Fears; NEGE-r, Negative Emotionality/Neuroticism–revised; NFC, Inefficacy; NUC, Neurological 
Complaints; PSYC-r, Psychoticism-revised; RC1, Somatic Complaints; RC2, Low Positive Emotions; RC3, Cynicism; RC4, Antisocial Behavior; RC6, Ideas of Persecution; 
RC7, Dysfunctional Negative Emotions; RC8, Aberrant Experiences; RC9, Hypomanic Activation; RCd, Demoralization; SAV, Social Avoidance; SFD, Self-Doubt; SHY, 
shyness; sTW, stress/Worry; sUB, substance abuse; sUi, suicidal/Death ideation; ThD, Thought Dysfunction.
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Table 6 Multinomial logistic regression analysis: final model (criterion: group differences)
Effect Model fitting  
criteria
Likelihood ratio  
tests
95% CI of odds ratio
-2 log likelihood  
of reduced model
χ2 df P, OR Lower  
bound
Upper  
bound
P,
Likelihood ratio tests
Final model
 Women 165.31 21.34 2 ,0.001 Patients 0.12 0.02 0.78 0.05
– – – – First-degree relatives 3.35 0.92 12.13 0.07
 living alone 153.31 9.35 2 0.01 Patients 0.08 0.01 0.51 0.01
– – – – First-degree relatives 0.20 0.05 0.80 0.05
 school #8 years 150.64 6.67 2 0.05 Patients 1.26 0.18 8.93 0.82
– – – – First-degree relatives 5.16 1.12 23.82 0.05
  Physical  
comorbidities
157.36 13.39 2 0.001 Patients 27.43 3.17 237.50 0.01
– – – – First-degree relatives 1.25 0.40 3.89 0.70
 TRIN-r 153.39 9.42 2 0.01 Patients 1.99 1.22 3.22 0.01
– – – – First-degree relatives 1.23 0.87 1.74 0.24
 Mls 156.75 12.78 2 0.01 Patients 1.88 1.15 3.08 0.05
– – – – First-degree relatives 0.90 0.64 1.27 0.55
 BrF 149.26 5.29 2 0.07 Patients 0.73 0.41 1.31 0.29
– – – – First-degree relatives 1.22 0.84 1.76 0.30
 Physical health 147.24 3.27 2 0.20 Patients 0.98 0.92 1.05 0.60
– – – – First-degree relatives 0.96 0.91 1.01 0.10
Pearson Nagelkerke R2
-2 log likelihood χ2 df P,
Final model fitting statistics
101.27 101.27 16 ,0.001 342.46 216 ,0.001 0.66
Abbreviations: BRF, Behavior-Restricting Fears; CI, confidence interval; MLS, Malaise; OR, odds ratio; TRIN-r, True Response Inconsistency.
Table 5 Partial multivariate models (criterion: groups)
Effect Model fitting  
criteria
Likelihood ratio tests
-2 log likelihood χ2 df P,
Likelihood ratio tests
Model 1
 sex 178.07 22.54 2 ,0.001
 age 159.30 3.76 2 0.15
 living alone 165.83 10.29 2 0.01
 school #8 years 162.70 7.16 2 0.05
  Physical  
comorbidities
169.60 14.07 2 0.001
Model 2
 TRIN-r 234.17 11.37 2 0.01
 F-r 223.97 1.17 2 0.56
 Fs 225.26 2.46 2 0.29
 FBS-r 225.70 2.90 2 0.24
Model 3
 rc3 210.02 2.33 2 0.31
 Mls 220.26 12.57 2 0.01
 cOg 211.51 3.82 2 0.15
 hlP 212.69 5.00 2 0.08
 NFc 208.91 1.22 2 0.54
 BrF 217.20 9.51 2 0.01
Abbreviations: BRF, Behavior-Restricting Fears; COG, Cognitive Complaints; F-r, 
Infrequent Responses; FBS-r, Symptom Validity; Fs, Infrequent Somatic Responses; 
HLP, Helplessness/Hopelessness; MLS, Malaise; NFC, Inefficacy; RC3, Cynicism; 
TRIN-r, True Response Inconsistency.
The factors enlisted as causes of distress in patients 
with MPM (eg, legal battles for financial compensation 
and anger toward employers) may cause disappoint-
ment and lack of trust among caregivers and patients. 
Furthermore, feelings of helplessness/hopelessness and 
behavior-restricting fears are other common features 
among caregivers who look after patients with MPM. Some 
studies have supported the concept that younger, relatively 
poor caregivers who are actively providing care to their 
relatives for several years may benefit from interventions 
to improve their QoL.17,21
Now we have to consider some limitations to the gen-
eralizability of the results. First, the number of patients 
with MPM was quite low, due to the short survival times. 
Moreover, some contrasts could not be significant due to the 
low power of the analyses. Furthermore, the low number of 
subjects in some groups may have caused wider confidence 
intervals in the multivariate analysis. Second, despite the 
fact that we excluded patients with any DSM-IV-TR Axis I 
or Axis II diagnosis, we did not use well-accepted measures 
to screen for depressive and anxiety symptomatology. Third, 
we only used self-report measures that were potentially 
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affected by social desirability bias, and − despite the validity 
of all the MMPI protocols − our results have shown some 
 differences between groups for scales of validity, with 
patients and caregivers having higher scores than controls. 
Fourth, controls differed between patients and their rela-
tives for several socio-demographic variables, even after 
controlling for other variables. Nevertheless, our research 
is the first systematic study investigating personality traits 
and QoL in MPM patients and their relatives who provide 
direct care.
Conclusion
Patients with MPM have poorer physical health, and they report 
a general feeling of malaise, cognitive symptoms, inefficacy, 
helplessness, and hopelessness. Caregivers, meanwhile, often 
report feelings of inefficacy and helplessness, and they lack 
trust in people. Due to the fact that the QoL of family caregivers 
and patients with cancer can vary along the illness trajectory,22 
health care providers should assess the ongoing adjustment and 
emotional wellbeing of people with MPM and their relatives. 
After all, poorly recognized distress could lead to difficulties in 
making decisions about treatment, and poor adherence to medi-
cal treatment, and among family caregivers, lower engagement 
in health behaviors, such as cancer screening. Family-based 
psychoeducational programs and support groups for people 
affected by MPM and their family members may help to reduce 
the distress in patients and caregivers, improving their quality 
of life and lowering levels of caregiver burden.23,24 Neverthe-
less, to date, we have no controlled studies investigating the 
effectiveness of psychological interventions aimed to reduce 
emotional distress in MDM patients and their caregivers. Thus, 
future research is needed to identify guidelines for psychologi-
cal best practices (through process and outcome studies). In 
this perspective, the assessment of personality traits in MDM 
patients and their caregivers could orient the intervention, with 
the aims of activating and reinforcing adherence to treatment 
and improving QoL.
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